<DOC>
	<DOCNO>NCT00162305</DOCNO>
	<brief_summary>The purpose clinical research study ass safety , exposure , biological effect BMS-512148 stable Type 2 diabetic subject</brief_summary>
	<brief_title>A Phase IIA Study BMS-512148 Assess Safety , Exposure , Biological Effects Stable Type 2 Diabetic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Established diagnosis Type 2 diabetes mellitus , treat metformin diet alone ( drug naive ) . Fasting glucose ( FG ) &lt; 240 mg/dL , metformin antidiabetic diet alone . HbA1c ( Hemoglobin A1c ) range 6.010.0 % Women childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>